DB16524Experimental
FINLAY-FR-1, also known as Soberana 01, is a vaccine candidate for COVID-19 that is being led developmentally by the Finlay Vaccine Institute . It is currently being tested in the... It is currently being tested in the clinical trial RPCEC00000332 (Phase I / II, randomized, controlled, adaptive, double-blind and multicenter study to evaluate the safety, reactogenicity and immunogenicity, of the prophylactic FINLAY-FR-1 anti-SARS-CoV-2 Vaccine Candidate...
- Also known as
- FINLAY-FR-1 anti-SARS-CoV-2 vaccine candidate · Soberana 01
- Code names
- FINLAY-FR-1
What you can answer from here — as of March 06, 2025
Which companies are running trials of FINLAY-FR-1, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account